Research work · 2004

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso

Nature Medicine

Read free full text

DOI: 10.1038/nm988